Browse by UCL people
Group by: Type | Date
Number of items: 35.
Article
Arachchillage, DRJ;
Mackie, IJ;
Efthymiou, M;
Chitolie, A;
Hunt, BJ;
Isenberg, DA;
Khamashta, M;
... Cohen, H; + view all
(2016)
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
Journal of Thrombosis and Haemostasis
, 14
(11)
pp. 2177-2186.
10.1111/jth.13475.
|
 |
|
Balbi, Gustavo GM;
Ahmadzadeh, Yasaman;
Tektonidou, Maria G;
Pengo, Vittorio;
Sciascia, Savino;
Ugarte, Amaia;
Belmont, H Michael;
... Oliveira de Andrade, Danieli Castro; + view all
(2024)
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Rheumatology
, 63
(3)
pp. 772-779.
10.1093/rheumatology/kead292.
|
|
Benjamin, LA;
Paterson, RW;
Moll, R;
Pericleous, C;
Brown, R;
Mehta, PR;
Athauda, D;
... Efthymiou, M; + view all
(2021)
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
EClinicalMedicine
, Article 101070. 10.1016/j.eclinm.2021.101070.
(In press).
|
|
|
Cecchi, Irene;
Radin, Massimo;
Foddai, Silvia Grazietta;
Barinotti, Alice;
Andrade, Danieli;
Tektonidou, Maria G;
Pengo, Vittorio;
... Sciascia, Savino; + view all
(2025)
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the APS ACTION Clinical Database and Repository.
Rheumatology
, 64
(5)
pp. 2862-2867.
10.1093/rheumatology/keae583.
|
|
Chighizola, Cecilia B;
Pregnolato, Francesca;
Andrade, Danieli;
Tektonidou, Maria;
Pengo, Vittorio;
Ruiz-Irastorza, Guillermo;
Belmont, H Michael;
... AntiPhospholipid Syndrome Alliance For Clinical Trials and Inter, .; + view all
(2023)
Fluctuation of Anti-Domain 1 and Anti-Β2 Glycoprotein I Antibody Titers Over Time in Patients with Persistently Positive Antiphospholipid Antibodies.
Arthritis & Rheumatology
, 75
(6)
pp. 984-995.
10.1002/art.42459.
|
|
Cohen, H;
Efthymiou, M;
Devreese, KMJ;
(2021)
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
Journal of Thrombosis and Haemostasis
, 19
(4)
pp. 892-908.
10.1111/jth.15217.
|
|
Cohen, Hannah;
Werring, David J;
Chandretheva, Arvind;
Mittal, Prabal;
Devreese, Katrien MJ;
Isenberg, David A;
ISTH SSC LA/aPL Subcommittee Study Group;
(2023)
Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Journal of Thrombosis and Haemostasis
, 21
(10)
pp. 2963-2976.
10.1016/j.jtha.2023.06.020.
|
|
Cohen, H;
Efthymiou, M;
Gates, C;
Isenberg, D;
(2018)
Direct Oral Anticoagulants for Thromboprophylaxis in Patients with Antiphospholipid Syndrome.
Seminars in Thrombosis and Hemostasis
, 44
(05)
pp. 427-438.
10.1055/s-0036-1597902.
|
|
|
Cohen, H;
Efthymiou, M;
Isenberg, DA;
(2018)
Use of direct oral anticoagulants in antiphospholipid syndrome.
Journal of Thrombosis and Haemostasis
, 16
(6)
pp. 1028-1039.
10.1111/jth.14017.
|
|
Cohen, H;
Hunt, BJ;
Efthymiou, M;
Arachchillage, DR;
Mackie, IJ;
Clawson, S;
Sylvestre, Y;
... RAPS trial investigators, .; + view all
(2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Lancet Haematology
, 3
(9)
e426-e436.
10.1016/S2352-3026(16)30079-5.
|
|
|
Cohen, H;
Sayar, Z;
Efthymiou, M;
Gaspar, P;
Richards, T;
Isenberg, D;
(2020)
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome.
The Lancet Haematology
, 7
(8)
e613-e623.
10.1016/S2352-3026(20)30116-2.
|
|
Efthymiou, M;
Lane, PJ;
Isenberg, D;
Cohen, H;
Mackie, IJ;
(2022)
Comparison of acquired activated protein C resistance, using the CAT and ST-genesia® analysers and three thrombin generation methods, in APS and SLE patients.
Journal of Clinical Medicine
, 11
(1)
, Article 69. 10.3390/jcm11010069.
|
|
|
Efthymiou, Maria;
Bertolaccini, Maria Laura;
Cohen, Hannah;
(2024)
Viewpoint: Lupus anticoagulant detection and interpretation in antiphospholipid syndrome.
Rheumatology
, 63
(SI)
SI54-SI63.
10.1093/rheumatology/kead623.
|
|
|
Efthymiou, M;
Arachchillage, DRJ;
Lane, PJ;
O'Keeffe, AG;
McDonnell, T;
Cohen, H;
Mackie, IJ;
(2018)
Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome.
Thrombosis Research
, 170
pp. 60-68.
10.1016/j.thromres.2018.08.003.
|
|
Efthymiou, M;
Mackie, IJ;
Lane, PJ;
Andrade, D;
Willis, R;
Erkan, D;
Sciascia, S;
... APS ACTION, .; + view all
(2019)
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository.
Journal of Thrombosis and Haemostasis
, 17
(12)
pp. 2069-2080.
10.1111/jth.14596.
|
|
Erton, Zeynep Belce;
Leaf, Rebecca K;
de Andrade, Danieli;
Clarke, Ann;
Tektonidou, Maria G;
Pengo, Vittorio;
Sciascia, Savino;
... Erkan, Doruk; + view all
(2025)
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (“Registry”).
Lupus
, 34
(6)
pp. 617-625.
10.1177/09612033251332258.
|
|
Gaspar, Pedro;
Farinha, Filipa;
Sayar, Zara;
Efthymiou, Maria;
Cohen, Hannah;
Isenberg, David A;
(2022)
A one-point increase in the Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality in thrombotic antiphospholipid syndrome.
Clinical and Experimental Rheumatology
10.55563/clinexprheumatol/0gs167.
(In press).
|
|
Gkrouzman, E;
Sevim, E;
Finik, J;
Andrade, D;
Pengo, V;
Sciascia, S;
Tektonidou, MG;
... APS ACTION+; + view all
(2021)
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results from APS ACTION Clinical Database and Repository.
Journal of Rheumatology
, 48
(4)
pp. 541-547.
10.3899/jrheum.200513.
|
|
Gkrouzman, Elena;
Willis, Rohan;
Andrade, Danieli;
Tektonidou, Maria G;
Pengo, Vittorio;
Ruiz-Irastorza, Guillermo;
Belmont, H Michael;
... APS, ACTION; + view all
(2023)
Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
Laboratory Investigation
, 103
(6)
, Article 100147. 10.1016/j.labinv.2023.100147.
|
|
Lawrie, AS;
Kitchen, S;
Efthymiou, M;
Mackie, IJ;
Machin, SJ;
(2013)
Determination of APTT factor sensitivity - the misguiding guideline.
Int J Lab Hematol
, 35
(6)
pp. 652-657.
10.1111/ijlh.12109.
|
 |
|
Mittal, Prabal;
Gafoor, Rafael;
Sayar, Zara;
Efthymiou, Maria;
Tohidi-Esfahani, Ibrahim;
Appiah-Cubi, Stella;
Arachchillage, Deepa J;
... Cohen, Hannah; + view all
(2024)
Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial.
Research and Practice in Thrombosis and Haemostasis
, 8
(5)
, Article e102468. 10.1016/j.rpth.2024.102468.
|
|
|
Paterson, RW;
Benjamin, LA;
Mehta, PR;
Brown, RL;
Athauda, D;
Ashton, NJ;
Leckey, CA;
... Schott, JM; + view all
(2021)
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Brain Communications
, 3
(3)
, Article fcab099. 10.1093/braincomms/fcab099.
|
|
|
Radin, M;
Sciascia, S;
Erkan, D;
Pengo, V;
Tektonidou, MG;
Ugarte, A;
Meroni, P;
... APS ACTION; + view all
(2019)
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Seminars in Arthritis and Rheumatism
, 49
(3)
pp. 464-468.
10.1016/j.semarthrit.2019.04.009.
|
|
Ramirez, GA;
Mackie, I;
Nallamilli, S;
Pires, T;
Moll, R;
Pericleous, C;
Isenberg, DA;
... Efthymiou, M; + view all
(2021)
Anti-protein C antibodies and acquired protein C resistance in SLE: novel markers for thromboembolic events and disease activity?
Rheumatology
, 60
(3)
pp. 1376-1386.
10.1093/rheumatology/keaa509.
|
|
Ramirez, GA;
Efthymiou, M;
Isenberg, DA;
Cohen, H;
(2019)
Under crossfire: thromboembolic risk in systemic lupus erythematosus.
Rheumatology
, 58
(6)
pp. 940-952.
10.1093/rheumatology/key307.
|
|
Sayar, Z;
Nallamilli, S;
Efthymiou, M;
Lambert, J;
Cohen, H;
(2021)
Coexistent antiphospholipid syndrome and myeloproliferative neoplasm.
Lupus
, 30
(9)
pp. 1502-1508.
10.1177/09612033211021154.
|
|
|
Sciascia, S;
Willis, R;
Pengo, V;
Krilis, S;
Andrade, D;
Tektonidou, MG;
Ugarte, A;
... APS ACTION, .; + view all
(2019)
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
Thrombosis Research
, 175
pp. 32-36.
10.1016/j.thromres.2019.01.010.
|
|
Sevim, E;
Zisa, D;
Andrade, D;
Sciascia, S;
Pengo, V;
Tektonidou, MG;
Ugarte, A;
... APS ACTION Investigators; + view all
(2022)
Characteristics of Antiphospholipid Antibody Positive Patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking.
Arthritis Care & Research
, 74
(2)
pp. 324-335.
10.1002/acr.24468.
|
|
Unlu, O;
Erkan, D;
Barbhaiya, M;
Andrade, D;
Nascimento, I;
Rosa, R;
Banzato, A;
... APS ACTION, .; + view all
(2019)
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Arthritis Care & Research
, 71
(1)
pp. 134-141.
10.1002/acr.23584.
|
|
Venturelli, Veronica;
Maranini, Beatrice;
Tohidi-Esfahani, Ibrahim;
Isenberg, David A;
Cohen, Hannah;
Efthymiou, Maria;
(2024)
Can complement activation be the missing link in antiphospholipid syndrome?
Rheumatology
, Article keae178. 10.1093/rheumatology/keae178.
(In press).
|
|
Yelnik, CM;
Erton, ZB;
Drumez, E;
Cheildze, D;
de Andrade, D;
Clarke, A;
Tektonidou, MG;
... Erkan, D; + view all
(2024)
Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”).
Seminars in Arthritis and Rheumatism
, 65
, Article 152347. 10.1016/j.semarthrit.2023.152347.
|
|
Zuily, S;
Clerc-Urmes, I;
Bauman, C;
Andrade, D;
Sciascia, S;
Pengo, V;
Tektonidou, MG;
... Erkan, D; + view all
(2020)
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Lupus
, 29
(11)
pp. 1353-1363.
10.1177/0961203320940776.
|
|
|
Zuo, Y;
Navaz, S;
Tsodikov, A;
Kmetova, K;
Kluge, L;
Ambati, A;
Hoy, CK;
... Lockshin, M; + view all
(2023)
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
Arthritis & Rheumatology
10.1002/art.42489.
(In press).
|
|
Proceedings paper
|
Efthymiou, M;
Mackie, IJ;
Lane, P;
Erkan, D;
Cohen, H;
(2017)
High prevalence of activated protein C resistance associated with high avidity anti-protein C antibodies in various antiphospholipid syndrome clinical phenotypes.
In:
(Proceedings) ISTH 2017.
|
|
Conference item
|
Ramirez, G;
Cohen, H;
Mackie, I;
Isenberg, D;
Efthymiou, M;
(2018)
Prevalence of anti-protein C antibodies and acquired activated protein C resistance and in systemic lupus erythematosus.
Presented at: British Society for Haemostasis and Thrombosis, Coventry, UK.
|
|
